Koichi Minato

机构：Hyogo Prefectural Cancer Center, Gunma Prefectural Cancer Center

发表论文 269 篇 · 总被引 4449 次 · h-index 35

代表论文

• Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR (2022 · Journal of Clinical Oncology · 被引 93)
• A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in patients with cancer cachexia and low body mass index (2022 · Cancer · 被引 46)
• Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer (2021 · Cancer Medicine · 被引 36)
• First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA (2022 · International Journal of Clinical Oncology · 被引 33)
• Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer (2022 · Cancer Medicine · 被引 32)
• A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study) (2023 · European Journal of Cancer · 被引 23)